Greyson International, Inc. Receives Successful Clinical Study Results On Revolutionary Delivery System Trilexon(R)

Greyson International, Inc. (GYSN.PK) announced that it has received results from a third-party clinical study conducted on Trilexon®, a new delivery system designed by Greyson that improves the effectiveness of topical applications. Trilexon® Line Smoother, Trilexon® Eye Cr??me and Trilexon® Night Cr??me are the first skincare products to utilize the unique delivery system, which precisely delivers key ingredients to the appropriate areas through "messengers" in order to achieve higher effectiveness and more noticeable results.


"We are proud to announce the success of Trilexon® in a third-party clinical study," said Greyson International CEO Harvey Tauman. "These findings validate what we have believed from the beginning-that Trilexon® is the latest and most effective technology to be introduced in the skincare market. This clinical study proves that Trilexon® delivers extraordinary results, above and beyond existing delivery systems found in today's topical applications."


The clinical study reviewed four different points, including Ph levels to determine the effectiveness of the delivery system, protein and skin lipid levels to determine the length of time the delivery system remains on the skin, time release of ingredients on the skin and skin barrier penetration of ingredients. On all four points, Trilexon® performed to the highest level, confirming that it is effective, remains on the skin, releases ingredients over time and penetrates the skin barrier to deliver active ingredients efficiently.


The independent study on Trilexon® was performed by Dr. Peter Pugliese, a world-renowned physician who has spent over 25 years studying specializing in aging mechanisms of human skin. Dr. Pugliese holds several patents, has published hundreds of articles and has lectured on every continent. He was awarded the Maison De Navarre Award for his contributions to cosmetic science. Dr. Pugliese has authored the textbook series Physiology of the Skin, which is a standard esthetic student reference. His latest textbook, Advanced Professional Skin Care, Medical Edition, replaced other teaching materials and has grown in use on a global level.


"As a chemist who has worked in the beauty and skincare industry for over 40 years, I am confident in stating that Trilexon® is one of the most significant advancements in delivery system technology that we have seen in decades," said Charles Fox, head of research and development for Greyson International. "The results from this clinical study provide us with the scientific evidence that we need to authenticate its effectiveness as we move forward and market Trilexon® through our own products and through licensing opportunities to beauty, skincare, health and pharmaceutical companies around the world."


Trilexon® also recently received trademark approval. Greyson International received confirmation that it is safe for use based on thorough safety testing on an independent panel of participants.


Source

Greyson International, Inc.